Confidential access
Built for the next billion-dollar exit window. A$3M to A$5M strategic growth round at approximately A$30M post-money.

Capital funds the United States launch, retention engineering, retail acceleration and the next hero SKU.
Comparable-company references are category timing context, not direct valuation comparables.



The strongest hydration brands are habit brands. Hyro has already turned flavour-led hydration into a subscription engine with lifetime gross-profit economics, not just transactional gross profit.
Reconciled cohort dataset across 19 cohorts, Skio, 2026-05-05. Most recent cohorts, Mar-Apr 2026, n=5,630, project the strongest M36 LTV in the dataset.
Hyro sits between medical hydration, sports drinks and premium wellness powders. Clinical-grade electrolyte load, zero added sugar, priced for daily use. The taste and design earn the repeat, the formula earns the trust.
| Brand | Positioning | Sodium | Added sugar | Cost / serve AU |
|---|---|---|---|---|
| Hyro | Playful performance | 500mg | 0g | ~A$1.07, ~A$0.85 on sub |
| Liquid I.V. | Medical hydration | 510mg | 11g | ~A$2.40 |
| Hydralyte | Sick-day rehydration | 490mg | 2g | ~A$1.50 |
| Gatorade | Sports performance | 270mg | 21g | ~A$3.50 |
| LMNT | Keto / endurance | 1,000mg | 0g | ~A$3.00 |
Source: competitor brand websites and Coles/Woolworths shelf checks, April 2026. Hyro delivers premium hydration at a daily-use price point, no premium cost burden on the customer.
Controlled compounding, not a one-off spike. Revenue scaled 100x while ad spend stayed disciplined and ROAS held above 3x. This is the shape of a brand finding product-market fit, not buying it.
Compound monthly growth across the tracked 24-month window.
Blended ROAS maintained through scale and stockout periods.
Source: Shopify sales by month, cross-checked to NAB Xero P&L. Excludes wholesale and US store. Dec-Jan dip reflects BFCM sellout and Christmas manufacturing closure.
Hyro became structurally subscription-led once the team built the engine properly. April 2026 averaged roughly 94 new subs per day, with peaks above 100.
Source: Skio snapshot, 2026-05-05. Active subscriber trajectory calibrated to reported active base.
LTV crosses CAC inside three months and compounds for the next 33. Payback this fast on a A$70 CAC is rare in DTC and rarer still in functional beverage.
Source: Skio cohort LTV, April 2024 to April 2026. M0-M16 actual, M17-M36 modelled at observed steady-state churn.
The strongest signal in the dataset: Mar-Apr 2026 cohorts, our largest acquisition months ever, project above the weighted average LTV. Quality is improving as scale increases, the opposite of what usually happens.
Source: Skio cohort retention export. Y-axis is percentage of cohort still subscribed.
Real revenue, real gross profit, real operating leverage. Margins expanding as the subscriber book matures. This is a business, not a marketing story.
FY25-26 gross margin ex GST.
Implied annual GP in the current subscriber book.
Source: NAB Xero P&L, July 2025 to March 2026. Shows revenue, gross profit and net profit trend before the raise-funded scale-up.
AU subs compounding, early US launch and Creatine live.
US scaled, wholesale expanded and Creatine compounding.
Multi-channel, multi-market daily-routine platform.
Operating targets used to frame the next funding event or strategic process. Not board-approved forecasts.
A lean operating team with AI leverage built in, backed by strategic creator-investors and meaningful prior capital. The team you fund delivers the plan.
1.3M+ audience. Co-creator of the hero flavour and a structural distribution partner.
Quade Cooper, Daly Cherry-Evans, Kendrick Louis and athlete network credibility.
Dan Churchill plus a broader founder-led creator-investor network that compounds trust.

The US Shopify Plus store is live. The brand already has proof in Australia. The round gives Hyro the inventory, creator activation and paid media fuel to move properly.
Hyro has an AI operating layer across growth, finance, supply chain, customer experience and founder leverage. This is a margin and speed lever in every function, not a tech bet.
This round is not open to passive capital. The right investor helps Hyro turn a proven Australian subscription engine into a global hydration platform.
Forward-looking statements are working scenarios, not board-approved forecasts. Final round terms subject to definitive documentation, board approval and customary diligence. Unit economics sourced from the Skio cohort LTV pack reconciled against Lifetimely blended CAC and Northbeam corrected spend. All financial figures stated ex GST.